New blood test could spot liver cancer sooner
NCT ID NCT07319299
First seen Jun 25, 2026 · Last updated Jun 25, 2026
Summary
This study is testing whether a new blood test score, called GAAD, can detect liver cancer earlier in people with chronic liver disease. The GAAD score combines a person's gender, age, and two blood markers (AFP and PIVKA-II). Researchers will compare the GAAD score to standard ultrasound and AFP tests in 2,100 participants over 24 months. The goal is to see if the GAAD score improves detection and reduces false alarms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Faculty of Medicine Siriraj Hospital
Bangkoknoi, Bangkok, 10700, Thailand
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GAAD score (blood test combining gender, age, AFP, and PIVKA-II)
What this could lead to
If successful, the GAAD score could become a standard, more accurate blood test to catch liver cancer early in people with chronic liver disease.
What could go wrong
This is a diagnostic study, not a treatment. The GAAD score may not prove significantly better than current methods, and results may not apply outside the specific patient group studied.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.